Az orvos-, egészségtudományi- és gyógyszerészképzés tudományos műhelyeinek fejlesztése(EFOP-3.6.3-VEKOP-16-2017-00009)
Támogató: EFOP-VEKOP
(TKP2021-EGA-25)
Introduc�on: Cardiovascular diseases are known to be associated with ac�va�on of
the complement system, however, the precise rela�onship between the two processes
is
partly unclear. The complement component C3a receptor (C3aR) has been iden�fied in
various
cell types within the mouse arterial wall and the vasoconstrictor effect of C3a may
be mediated
by resident macrophages in the adven��a via thromboxane A2 (TXA2) release, as found
by our
workgroup in previous research.
Aims: The primary objec�ve of this study was to determine the effects of chronic
angiotensin II (Ang II) administra�on on C3a-induced vasoconstric�on in mice, along
with
demonstra�ng the presence of macrophages in the adven��a using alterna�ve methods.
Methods: Changes in the isometric tension of the vascular segments were measured
using myography a�er isola�ng thoracic and abdominal aor�c segments of adult male
C57BL/6
mice. The mice were infused with either Ang II (520 ng/kg/min) or saline for 14 days
via microosmo�c pumps implanted in the subscapular region. qPCR assays were performed
to measure
the expression level of C3aR and the mouse macrophage marker F4/80. The expression
of
other genes involved in the signaling pathway, such as Cyclooxygenase 1 and 2 (Cox1
and
Cox2), thromboxane A synthase 1 (Tbxas1), and thromboxane A2 receptor (Tbxa2r), were
inves�gated. The localiza�on of C3AR1 was confirmed using immunohistochemistry. The
mechanism of the contrac�on was examined using the cyclooxygenase (COX) inhibitor
indomethacin and SQ29548, a thromboxane prostanoid (TP) receptor antagonist.
Results: An increased response to C3a (63–77) was observed in the vascular segments
due to the increased expression of C3aR caused by Ang II treatment compared to controls
that
received saline infusion. The qPCR results revealed an increase in the expression
of F4/80 and
C3aR in the aortas, par�cularly in the adven��a, due to Ang II infusion. A�er removing
the
endothelium, the vasoconstric�on increased, while the vessels became unresponsive
to C3a
a�er the administra�on of COX and TP receptor inhibitors and the removal of the adven��a.
Conclusion: It can be concluded from our results that chronic Ang II administra�on
can
lead to an enhanced vasoconstrictor response to C3a and an increased expression of
C3aR in
the aor�c wall, par�cularly in the adven��a where macrophages accumulate. Our findings
propose that the vasoconstric�on induced by C3a in the mouse aorta is facilitated
by
macrophages that have gathered in the adven��a. During the development of various
cardiovascular diseases, the effects of anaphylatoxins could be amplified and may
contribute
to the progression of the diseases